Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
33 Cards in this Set
- Front
- Back
chronic inflammation
|
inflammation of prolonged duration (often weeks to months), in which active inflammation, tissue destruction and repair are occurring simultaneously
- may follow acute inflammation or an injury elicits it from the beginning |
|
major causes of chronic inflammation
|
1. persistent infections (viruses, fungi, parasites, and mycobacteria)
2. autoimmune response - develops against a patient's own tissues (rheumatoid arthritis, systemic lupus erythematosus) 3. prolonged exposure to toxic agents - exposure to asbestos or coal; alcohol abuse |
|
morphologic features of chronic inflammation
|
1. infiltration with mononuclear cells (macrophages, lymphocytes, and plasma cells)
--> organized lymphoid tissue with germinal centers may form 2. tissue destruction --> due to persistence of injury 3. healing by connective tissue replacement --> fibrosis and angiogenesis (proliferation of blood vessels) |
|
macrophage functions in chronic inflammation
|
- dominant cell
- in tissues, monocytes differentiate into macrophages - substances secreted may result in tissue injury and fibrosis - some of the toxic products released: ROS, proteases - active proliferation at site and immobilization |
|
lymphocytes (chronic inflammation)
|
- recruited by macrophages
- interact closely with macrophages during response |
|
plasma cells (chronic inflammation)
|
- derived from B lymphocytes
- produce antibodies against persistent antigens |
|
eosinophils (chronic inflammation)
|
- involving IgE (usually allergic reactions) and in parasitic infections
- major basic protein --> main contents of cytoplasmic granules --> toxic to parasites |
|
mast cells (chronic inflammation)
|
- display a cell surface receptor for IgE
- produce cytokines that either promote or limit inflammation |
|
neutrophils (chronic inflammation)
|
- recruited by active macrophages and T lymphocytes
|
|
regeneration
|
- growth of cells and tissues to replace lost structures
-most common: skin, epithelia that line GI tract, and hematopoetic cells - requires: intact CT scaffold and viable stem cells - ECM is critical - compensatory growth in liver and kidney after partial hepatectomy or nephrectomy |
|
healing with scar formation
|
- common response to wound or chronic inflammation
- extracellular matrix is damaged - insufficient numbers of viable stem cells - original tissue cannot fully be reconstituted - fibroblasts are activated to lay down collagen |
|
stem cells
|
undifferentiated cells which are characterized by their prolonged capacity for self renewal and asymmetric replication
|
|
asymmetric replication
|
some will remain undifferentiated and continue to self replicate, while others will mature and differentiate into a non dividing, specialized cell
|
|
embryonic stem cells
|
- pluripotent (multiple potential) cells
- differentiate into all the specialized tissues of the human body |
|
adult stem cells
|
- specific sites within multiple organs
- more limited capacity for differentiation - reconstitute the organ in which they reside |
|
epidermal growth factor (EGF)
|
- stimulates growth of a variety of epithelial tissues, hepatocytes, fibroblasts
- produced by keratinocytes in the skin, macrophages, and other inflammatory cells |
|
hepatocyte growth factor (HGF)
|
- stimulates growth in various epithelial cells, including hepatocytes and bile duct cells
- promotes cell migration in development - produced mainly by fibroblasts and endothelial cells - many tumors express receptors for HGF |
|
vascular endothelial growth factor (VEGF)
|
- induces formation of blood vessels (vasculogenesis and angiogenesis)
- setting of chronic inflammation, wound healing, and tumor growth |
|
platelet-derived growth factor (PDGF)
|
- proliferation and migration of fibroblasts, smooth muscle cells, and monocytes
- produced by platelets, activated macrophages, and endothelial cells |
|
fibroblast growth factor (FGF)
|
- produced by a variety of cells
- important for migration of macrophages, endothelial cells and fibroblasts into damaged tissues for wound repair - stimulates growth of keratinocytes in skin, promotes angiogenesis, hematopoesis and development |
|
transforming growth factor beta (TGF-beta)
|
- potent stimulator of fibrosis
- proliferation of fibroblasts and smooth muscle - activates fibroblasts - enhances the production of collagen and other components - produced by macrophages, endothelial cells and platelets |
|
granulation tissue
|
- specialized type of tissue reaction to injury
- consists of new small blood vessels and proliferating, activated fibroblasts - often leaky --> edematous or reddened appearance due to leakage of proteins and RBCs - may start early scar formation (collagen) |
|
angiogenesis
|
- formation of new blood vessels in adults
- critical factor in the growth of tumors and the re-vascularization of tissue with inadequate blood supply mechanisms: 1. growth from endothelial precursor cells 2. growth from pre-existing vessels --> VEGF (important), also PDGF and TGF-beta |
|
fibroblast migration and proliferation
|
- migration and proliferation of fibroblasts is stimulated by growth factors (TGF-beta, PDGF, EGF)
- secreted by macrophages at site of injury |
|
deposition of the ECM
|
- most of the growth factors that promote fibroblast proliferation also stimulate the synthesis of collagen
- collagen type III--> one of the first collagens to be laid down - loose and "young" - as repair progresses, angiogenesis ceases, number of endothelial cells and fibroblasts decreases --> avascular pale scar |
|
tissue remodeling
|
- change in components of ECM
--> transition from collagen type III to denser and more mature collagen type I - remodeled and shaped to a density and size that is optimal for the anatomic site and tissue type - degradation of unnecessary collagen and proteins by metalloproteinases (MMPs) |
|
scar formation
|
1. fibroblast migration and proliferation
2. deposition of the ECM 3. tissue remodeling |
|
cutaneous wound healing
|
- single injurious event (wound or cut to the skin) that is over quickly and the body is then allowed to heal without ongoing injury
1. inflammation --> blood clot formation --> inflammation 2. proliferation --> granulation tissue formation and re-epithelialization of skin 3. maturation --> ECM deposition, scar maturation, wound contraction, recovery of tensile strength |
|
first intention
|
"primary union"
- tissue edges are closely approximated, as in surgical incision) |
|
second intention
|
- filling in of a large defect with separated edges, usually due to significant tissue loss
|
|
factors that impact wound healing
|
systemic factors
1. nutritional status 2. circulatory status 3. diseases such as diabetes 4. use of anti-inflammatory medications such as glucocorticoids local factors: 1. infection (most important) 2. mechanical factors 3. size, location, and type of wound |
|
complications in wound healing
|
1. deficient scar formation --> wound separation or ulceration
2. excessive tissue formation 3. formation of contractures --> distortion of the scar or adjacent structures (severe burns) |
|
fibrosis associated with chronic inflammation
|
often involve continuous tissue injury and active inflammation, due to persistence of initial stimulus
|